The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "View PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.
Did you know that opioid dependence affects people from all walks of life, without social, economic, or educational boundaries? Many nurses, like you, have observed that an increasing number of patients in their practices are opioid dependent.
Nurses play a crucial role in opioid-dependence treatment. In fact, you may be one of the first professionals a patient comes in contact with when he or she seeks help.
As you many know, pharmacotherapy with SUBOXONE (buprenorphine HCl/naloxone HCl dihydrate sublingual tablets) (CIII) can address the biological basis of opioid dependence by helping to suppress withdrawal symptoms and decrease drug cravings. With their physical symptoms under control, patients can be retained in treatment and focus on psychosocial counseling. (Click here to view the full Prescribing Information.)
In response to requests from nurses for information to enhance their knowledge and support them in their interactions with opioid dependent patients, we would like to offer you the following information in the Frequently Asked Questions link below.
